153 related articles for article (PubMed ID: 36995458)
1. Mixed adenoneuroendocrine carcinoma originating from the appendix and colorectum: a comparative analysis of a large population-based database.
Zhao B; Wang J; Ye H; Cheng X; Meng K; Yang T
Tech Coloproctol; 2023 Nov; 27(11):1017-1024. PubMed ID: 36995458
[TBL] [Abstract][Full Text] [Related]
2. Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity.
Brathwaite S; Rock J; Yearsley MM; Bekaii-Saab T; Wei L; Frankel WL; Hays J; Wu C; Abdel-Misih S
Ann Surg Oncol; 2016 Jul; 23(7):2281-6. PubMed ID: 26965701
[TBL] [Abstract][Full Text] [Related]
3. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis.
Grossi U; Bonis A; Carrington EV; Mazzobel E; Santoro GA; Cattaneo L; Centonze G; Gallo G; Kazemi Nava A; Romano M; Di Tanna GL; Zanus G
Eur J Surg Oncol; 2021 Nov; 47(11):2893-2899. PubMed ID: 34052038
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
Mao W; Lyu Y; Pu N; Li J; Xin B; Chen W; Jin D; Lou W; Xu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):564-568. PubMed ID: 29774940
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
[TBL] [Abstract][Full Text] [Related]
6. Appendiceal Mixed Adeno-Neuroendocrine Carcinoma: A Population-Based Study of the Surveillance, Epidemiology, and End Results Registry.
Brathwaite S; Yearsley MM; Bekaii-Saab T; Wei L; Schmidt CR; Dillhoff ME; Frankel WL; Hays JL; Wu C; Abdel-Misih S
Front Oncol; 2016; 6():148. PubMed ID: 27379210
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends.
Wang J; He A; Feng Q; Hou P; Wu J; Huang Z; Xiao Z; Sun C; Liao W; Wu L
J Transl Med; 2020 Mar; 18(1):128. PubMed ID: 32169074
[TBL] [Abstract][Full Text] [Related]
8. Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile and predictors.
Onyemkpa C; Davis A; McLeod M; Oyasiji T
J Gastrointest Oncol; 2019 Apr; 10(2):300-306. PubMed ID: 31032098
[TBL] [Abstract][Full Text] [Related]
9. [Mixed adenoneuroendocrine carcinoma (MANEC) of the gastrointestinal tract].
Šefr R; Němec L; Fabian P; Fiala L
Rozhl Chir; 2017; 96(1):41-44. PubMed ID: 28325058
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of colorectal mixed adenoneuroendocrine carcinoma and adenocarcinoma with neuroendocrine differentiation: a population-based study.
Song LJ; Yuan L
Int J Clin Exp Pathol; 2019; 12(3):922-932. PubMed ID: 31933902
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
Dulskas A; Pilvelis A
Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
[TBL] [Abstract][Full Text] [Related]
13. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
Gao R; Chen XY; Jin L
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
[No Abstract] [Full Text] [Related]
14. Diagnosis, Assessment, and Therapeutic Strategy for Colorectal Mixed Adenoneuroendocrine Carcinoma.
Tanaka T; Kaneko M; Nozawa H; Emoto S; Murono K; Otani K; Sasaki K; Nishikawa T; Kiyomatsu T; Hata K; Morikawa T; Kawai K; Watanabe T
Neuroendocrinology; 2017; 105(4):426-434. PubMed ID: 28641295
[TBL] [Abstract][Full Text] [Related]
15. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature.
Zhang L; DeMay RM
Diagn Cytopathol; 2014 Dec; 42(12):1075-84. PubMed ID: 24554593
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of an ascending colon mixed adenoneuroendocrine carcinoma with clinical serosal invasion.
Liu XJ; Feng JS; Xiang WY; Kong B; Wang LM; Zeng JC; Liang YF
Int J Clin Exp Pathol; 2014; 7(9):6395-8. PubMed ID: 25337298
[TBL] [Abstract][Full Text] [Related]
17. Comparison of survival outcomes and survival prediction in patients with primary colorectal MANEC and primary colorectal SRCC: a population-based propensity-score matching study.
Zhu Y; Thandar M; Cheng J; Zhang X; Zhao Z; Huang S; Chi P
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13279-13300. PubMed ID: 37481754
[TBL] [Abstract][Full Text] [Related]
18. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis.
Kojima M; Ikeda K; Saito N; Sakuyama N; Koushi K; Kawano S; Watanabe T; Sugihara K; Ito M; Ochiai A
Front Oncol; 2016; 6():173. PubMed ID: 27486567
[TBL] [Abstract][Full Text] [Related]
20. Mixed adenoneuroendocrine carcinoma: A review of pathologic characteristics.
Brathwaite SA; Smith SM; Wai L; Frankel W; Hays J; Yearsley MM; Abdel-Misih S
Hum Pathol; 2018 Mar; 73():184-191. PubMed ID: 29288693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
